Quarterly report · Q2
2667.TEDINET S100TFYI
Period2023-10-01 → 2024-03-31
Filed2024-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Amended by S100V5WK (2025-01-31).
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.3bn | 2023-10-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥3.0bn | 2022-10-01 → 2023-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.5bn | 2022-10-01 → 2023-03-31 | Cons. | Net sales |
| Operating income | −¥230m | 2023-10-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | −¥136m | 2022-10-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | −¥235m | 2023-10-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥713m | 2022-10-01 → 2023-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥152m | 2022-10-01 → 2023-03-31 | Cons. | Ordinary income |
| Profit before tax | −¥388m | 2023-10-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | −¥68m | 2022-10-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥391m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥648m | 2022-10-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥83m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥391m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | −¥83m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥2.2bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥2.8bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥3.0bn | at 2023-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥806m | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥1.0bn | at 2023-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥1.4bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.8bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥2.4bn | at 2023-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥555m | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥876m | at 2023-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥555m | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥826m | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥630m | at 2022-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥70m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥39m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥794m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥194m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥247m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥215m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥8m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥91m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥82m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-36.48 | 2023-10-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-17.89 | 2024-01-01 → 2024-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-60.39 | 2022-10-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-7.69 | 2022-10-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥3.41 | 2023-01-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 63.0% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.2% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.3% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-03-31 | −¥172m |
| jpcrp040300-q2r_E02922-000Global Environment Solution Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥983m |
| jpcrp040300-q2r_E02922-000Global Environment Solution Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥983m |
| jpcrp040300-q2r_E02922-000Global Environment Solution Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | −¥2m |
| jpcrp040300-q2r_E02922-000Healthcare Solutionreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥268m |
| jpcrp040300-q2r_E02922-000Healthcare Solutionreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥268m |
| jpcrp040300-q2r_E02922-000Healthcare Solutionreportable segment | segment profit | 2023-10-01 → 2024-03-31 | −¥57m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-10-01 → 2024-03-31 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-10-01 → 2024-03-31 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-10-01 → 2024-03-31 | −¥59m |
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2023-03-31 | −¥201m |
| jpcrp040300-q2r_E02922-000Global Environment Solution Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥1.5bn |
| jpcrp040300-q2r_E02922-000Global Environment Solution Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥1.5bn |
| jpcrp040300-q2r_E02922-000Global Environment Solution Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥70m |
| jpcrp040300-q2r_E02922-000Healthcare Solutionreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥942m |
| jpcrp040300-q2r_E02922-000Healthcare Solutionreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥942m |
| jpcrp040300-q2r_E02922-000Healthcare Solutionreportable segment | segment profit | 2022-10-01 → 2023-03-31 | −¥5m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-10-01 → 2023-03-31 | ¥2.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-10-01 → 2023-03-31 | ¥2.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-10-01 → 2023-03-31 | ¥65m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 567
| Item | Context | Value | Unit |
|---|---|---|---|
| Decrease increase in real estate for sale in process ope cf | Prior1YTDDuration | － | JPY |
| Decrease increase in real estate for sale in process ope cf | CurrentYTDDuration | 578000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | -196624000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | -39235000 | JPY |
| Increase decrease in provision for bonuses ope cf | Prior1YTDDuration | 12570000 | JPY |
| Increase decrease in provision for bonuses ope cf | CurrentYTDDuration | -2724000 | JPY |
| Increase decrease in provision for product warranties ope cf | Prior1YTDDuration | 146000 | JPY |
| Increase decrease in provision for product warranties ope cf | CurrentYTDDuration | -2624000 | JPY |
| Increase decrease in net defined benefit liability ope cf | Prior1YTDDuration | 1497000 | JPY |
| Increase decrease in net defined benefit liability ope cf | CurrentYTDDuration | -1708000 | JPY |
| Stock issuance cost ope cf | Prior1YTDDuration | 48000 | JPY |
| Stock issuance cost ope cf | CurrentYTDDuration | － | JPY |
| Increase decrease in advances received ope cf | Prior1YTDDuration | － | JPY |
| Increase decrease in advances received ope cf | CurrentYTDDuration | 1801000 | JPY |
| Decrease increase in advance payments ope cf | Prior1YTDDuration | － | JPY |
| Decrease increase in advance payments ope cf | CurrentYTDDuration | 210016000 | JPY |
| Decrease increase in consumption taxes refund receivable ope cf | Prior1YTDDuration | － | JPY |
| Decrease increase in consumption taxes refund receivable ope cf | CurrentYTDDuration | -84161000 | JPY |
| Decrease increase in accounts receivable other ope cf | Prior1YTDDuration | － | JPY |
| Decrease increase in accounts receivable other ope cf | CurrentYTDDuration | 321000 | JPY |
| Increase decrease in accounts payable other ope cf | Prior1YTDDuration | － | JPY |
| Increase decrease in accounts payable other ope cf | CurrentYTDDuration | -17906000 | JPY |
| Increase decrease in accrued consumption taxes ope cf | Prior1YTDDuration | － | JPY |
| Increase decrease in accrued consumption taxes ope cf | CurrentYTDDuration | -112758000 | JPY |
| Loss gain on investments in partnership ope cf | Prior1YTDDuration | － | JPY |
| Loss gain on investments in partnership ope cf | CurrentYTDDuration | 5943000 | JPY |
| Special investigation expenses ope cf | Prior1YTDDuration | － | JPY |
| Special investigation expenses ope cf | CurrentYTDDuration | 95673000 | JPY |
| Past year settlement of accounts correction related cost ope cf | Prior1YTDDuration | － | JPY |
| Past year settlement of accounts correction related cost ope cf | CurrentYTDDuration | 39337000 | JPY |
| Gain on cancellation of contract ope cf | Prior1YTDDuration | － | JPY |
| Gain on cancellation of contract ope cf | CurrentYTDDuration | -7160000 | JPY |
| Loss on cancellation of contracts ope cf | Prior1YTDDuration | － | JPY |
| Loss on cancellation of contracts ope cf | CurrentYTDDuration | 4715000 | JPY |
| Issuance cost of subscription rights to shares ope cf | Prior1YTDDuration | 192000 | JPY |
| Issuance cost of subscription rights to shares ope cf | CurrentYTDDuration | － | JPY |
| Sales office closure costs ope cf | Prior1YTDDuration | 1380000 | JPY |
| Sales office closure costs ope cf | CurrentYTDDuration | － | JPY |
| Gain on sale of investments in capital of subsidiaries and associates ope cf | Prior1YTDDuration | -89700000 | JPY |
| Gain on sale of investments in capital of subsidiaries and associates ope cf | CurrentYTDDuration | － | JPY |
| Other net ope cf | Prior1YTDDuration | -46683000 | JPY |
| Other net ope cf | CurrentYTDDuration | -107000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | 727413000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | 25140000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YTDDuration | 1239000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 75000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -817000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -210000 | JPY |
| Income taxes paid refund ope cf | Prior1YTDDuration | -5653000 | JPY |
| Income taxes paid refund ope cf | CurrentYTDDuration | -7193000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |